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This study presents a detailed analysis of the acidic N-terminal region of the Orgyia pseudotsugata multicapsid nucle-
opolyhedrovirus (OpMNPV) transactivator IE1. The N-terminal region of IE1 is rich in acidic amino acids and has been
hypothesized to be an acidic activation domain. Removal of the N-terminal 126 amino acids containing the acidic domain of
IE1 resulted in complete loss of transactivation activity, indicating that this region is essential for transactivation. The
OpMNPV acidic domain was replaced with the archetype acidic activation domain from VP16 and the acid-rich region of
Autographa californica multicapsid NPV (AcMNPV) IE1. These chimeric constructs were fully capable of transactivation in
transient assays. The chimeric OpMNPV IE1s containing the herpes simplex virus VP16 and AcMNPV IE1 acidic activation
domains consistently transactivated a reporter gene to higher levels than the OpMNPV IE1 acidic activation domain.
Transactivation by the chimeric constructs is enhanced synergistically when cotransfected with IE2 into Lymantria dispar and
Spodoptera frugiperda cells. Both N- to C-terminal and C- to N-terminal deletions of the OpMNPV acidic activation domain
were constructed to define functional domains within the OpMNPV IE1 acidic activation domain. At least two potential
activation domains were identified. Within each of these domains, two core regions at amino acids 28–43 and amino acids
113–124 were identified that were similar to core regions of VP16 and GAL4, which contain predominately acidic and bulky
hydrophobic amino acids. © 1998 Academic Press
INTRODUCTION
The complete genomic sequences of Orgyia pseudot-
sugata multicapsid nucleopolyhedrovirus (OpMNPV) has
been determined and shown to be 131990 bases con-
taining 152 predicted open reading frames (ORFs) of
$150 nucleotides (Ahrens et al., 1997). The regulation of
these genes occurs as an ordered cascade of events
and appears to be controlled mainly at the level of tran-
scription (Friesen and Miller, 1986). Of primary impor-
tance in this regulatory cascade are the viral transcrip-
tional regulatory genes. In both OpMNPV and the arche-
type baculovirus Autographa californica NPV (AcMNPV),
three early genes have been shown to be transcriptional
regulatory proteins: IE1, IE2, and p34 (PE38) (Carson et
al., 1991a, 1991b; Kool et al., 1994; Kovacs et al., 1991;
Theilmann and Stewart, 1991, 1992a; Wu et al., 1993).
Due to its multiple roles and expression throughout
the viral life cycle, IE1 appears to be the single most
important regulatory gene of baculoviruses. IE1 from
both OpMNPV and AcMNPV has been shown to (1)
transactivate baculovirus early and late genes (Carson et
al., 1988; Guarino et al., 1986; Guarino and Summers,
1986a, 1986b; Kovacs et al., 1991; Lu and Carstens, 1993;
Nissen and Friesen, 1989; Passarelli and Miller, 1993;
Ribeiro et al., 1994; Theilmann and Stewart, 1991), (2)
inhibit expression from at least two early gene promoters
(ie0 and ie2 (Carson et al., 1991a; Kovacs et al., 1992,
1991; Theilmann and Stewart, 1992a), and (3) have an
essential role in viral DNA replication as indicated by
transient replication assays (Ahrens and Rohrmann,
1995; Kool et al., 1994).
OpMNPV and AcMNPV IE1 have been shown to be
powerful transcriptional transactivators that can increase
expression of reporter genes that are cis-linked to bac-
ulovirus enhancer elements up to 1000-fold (Guarino et
al., 1986; Guarino and Summers, 1986a; Kovacs et al.,
1991; Lu and Carstens, 1993; Passarelli and Miller, 1993;
Pullen and Friesen, 1995; Theilmann and Stewart, 1991).
Electrophoretic mobility shift assays have shown that
AcMNPV IE1 will bind either directly or indirectly to the
AcMNPV enhancer hr elements (Guarino and Dong,
1991; Leisy et al., 1995; Rodems et al., 1997). Additional
studies have shown that the AcMNPV enhancer ele-
ments will function with either OpMNPV IE1 or AcMNPV
IE1 (Theilmann and Stewart, 1991), indicating that the
OpMNPV and AcMNPV systems are somewhat inter-
changeable. IE1 transactivation is not dependent on cis-
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linked enhancer elements; studies have shown that
OpMNPV IE1 can also activate transcription from en-
hancerless promoters and from minimal promoters con-
taining only the TATA box and a transcriptional start site
(Blissard and Rohrmann, 1990; Theilmann and Stewart,
1991). However, Choi and Guarino (1995) have shown
that at low cellular concentrations of AcMNPV IE1, en-
hancers are required for detectable gene activation.
OpMNPV ie1 encodes a 560-amino-acid protein
whose predicted molecular mass is 64775 Da. The N-
terminal 132 amino acids of IE1 are rich in acidic resi-
dues, and a comparison of the predicted amino acid
sequences of OpMNPV IE1 and AcMNPV IE1 indicates
that there is only 21% sequence identity in the acidic
N-terminal region (Theilmann and Stewart, 1991). How-
ever, in the remaining C-terminal region, the sequence
identity increases to 55%. Although the OpMNPV IE1 and
AcMNPV IE1 N-terminal regions have essentially no se-
quence conservation, both maintain an acidic profile.
The net charge of the first 132 amino acids of OpMNPV
IE1 is 213 and 214 for the first 150 amino acids of
AcMNPV IE1. Consequently, IE1 is predicted to be a
member of the acidic class of transcriptional activators
similar to the HSV-1 protein, VP16 (Theilmann and Stew-
art, 1991). Kovacs et al. (1992) functionally dissected
AcMNPV IE1 into two principal domains, showing that
the N-terminal domain was required for transactivation
but did not affect DNA binding, whereas mutations in the
C-terminal region eliminated DNA binding. In an addi-
tional study by Slack and Blissard (1997), the authors
investigated the N-terminal region of AcMNPV IE1 in a
heterologous system that fused domains of AcMNPV IE1
to Escherichia coli Lac repressor protein and identified
two activation domains from amino acids 1–124 and
168–222. Rodems et al. (1997) also performed a muta-
tional analysis on AcMNPV IE1 and similarly showed that
amino acids 8–118 functioned as an activation domain
when fused to the yeast Gal4 DNA binding domain. In
addition, they identified a potential oligomerization do-
main from amino acid residues 543–568. This latter re-
gion has a high degree of amino acid sequence identity
with OpMNPV sequences, unlike the N-terminal acidic
domain.
In this study, we report on the characterization of the
acidic N-terminal region of the OpMNPV IE1 transactiva-
tor. To determine whether the OpMNPV IE1 acidic do-
main functions similarly to known acidic activation do-
mains, chimeric OpMNPV IE1s were constructed. In the
chimeric constructs, the native acidic domain was re-
placed with that of the archetype acidic activation do-
main from the herpes simplex virus transactivator VP16
and a second construct inserted the acidic domain from
AcMNPV IE1. The second objective of this study was to
define the minimal sequences of the OpMNPV IE1 acidic
domain that are required for transactivation. N-and C-
terminal deletions of the OpMNPV IE1 acidic domain
were constructed and functionally assayed using the
enhancer-dependent and -independent reporter gene
constructs: p39CAT-E3 and pIE1CAT, respectively (Theil-
mann and Stewart, 1992b).
RESULTS
Acidic domain replacement studies were carried out to
determine whether the OpMNPV IE1 acidic domain could
be functionally replaced by the archetype acidic activa-
tion domain from the herpes virus transcriptional activa-
tor VP16 (amino acids 413–490) (Cousens et al., 1989;
Sadowski et al., 1988; Triezenberg et al., 1988) and the
acidic domain of the IE1 gene of AcMNPV (amino acids
1–151). VP16 is the best known and most well character-
ized acidic activation domain and defines the acidic
class of transcriptional activation domains. Therefore, if
the OpMNPV IE1 acidic domain functions via a similar
mechanism, it should be able to be functionally replaced
by the VP16 acidic activation domain. Because AcMNPV
has a greater host range and virulence than OpMNPV,
we sought to determine whether the AcMNPV IE1 acidic
domain would affect the activation potential of the OpM-
NPV IE1 protein.
Alignment of the amino acid sequences of four known
IE1 proteins (Fig. 1) shows that the N-terminal region of
each IE1 protein contains a highly variable acidic domain
adjacent to a conserved cluster of basic amino acids.
Based on these comparisons, OpMNPV IE1 chimeric
proteins were constructed that inserted the foreign
acidic domain upstream from the conserved basic clus-
ter. Chimeric plasmids were constructed in which the
acidic domain of OpMNPV IE1 was replaced with the
78-amino-acid acidic activation domain of VP16 and the
151-amino-acid acidic domain of AcMNPV IE1 (Figs 2a
and 2b). These two constructs were called IE1-VP16AD
and IE1AcAD, respectively. As a result of the cloning
method, a glycine–proline dipeptide was inserted at
each end of the acidic domains. To control for these
modifications, an OpMNPV IE1-OpAD construct was
made in the same manner as the other constructs as
described under Materials and Methods. The net nega-
tive charge for the acidic domain of each of the chimeras
was 213, 216, and 221 for IE1-OpAD, IE1-AcAD, and
IE1-VP16AD, respectively (Fig. 2b).
To confirm that our IE1 chimeric constructs were ex-
pressed, we performed Western blot analysis on nuclear
protein extracts of transfected lepidopteran cell lines
(Fig. 3). The predicted molecular masses of IE1-OpAD,
IE1-VP16AD, and IE1-AcAD are 64.5, 59.5, and 67.5 kDa,
respectively. Using polyclonal antisera raised against
OpMNPV IE1, we detected IE1-specific proteins for IE1-
OpAD as well as the chimeric proteins in both Lymantria
dispar (Ld652Y) and Spodoptera frugiperda (Sf9) cells.
Figure 3 shows that all constructs were synthesized and
localized to the nucleus. The polyclonal antisera reacted
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very weakly with IE1-VP16 (Figs. 3a and 3b), despite the
fact that the antisera was produced by boosting rabbits
with only the C-terminal portion of IE1. However, despite
the weak signal in the Western blots, this protein, as
shown below, was highly active.
The ability of the chimeric constructs to function as
transactivators was determined by transient assay using
the reporter gene constructs p39CAT-E3 and pIE1CAT in
both Ld652Y and Sf9 cells. The p39CAT-E3 reporter con-
tains the CAT gene under control of the AcMNPV p39
early promoter and linked in cis to an OpMNPV enhancer
element at the 39 end (Theilmann and Stewart, 1992b).
Previous studies have shown this reporter gene con-
struct to express high levels of CAT when transactivated
by OpMNPV IE1. The pIE1CAT reporter plasmid has been
shown previously to be activated by IE1 and represents
enhancer-independent gene activation (Theilmann and
Stewart, 1991).
Comparison of IE1-OpAD and wild-type OpMNPV IE1
to transactivate reporter plasmids found no significant
differences in activation levels (data not shown). This
indicated that the inserted glycine and glycine–proline at
the N- and C-terminal ends of the OpMNPV IE1 acidic
domain in the IE1-OpAD construct had no observable
effect on the transactivation potential.
Figure 4a shows the CAT expression levels of
p39CAT-E3 cotransfected with the chimeric constructs
IE1-OpAD, IE1-VP16AD, and IE1-AcAD in Ld652Y cells.
Expression levels are shown relative to IE1-OpAD, which
was given the arbitrary value of 100. The acidic domain
deleted construct IE1-AD- did not transactivate, indicat-
ing that the acidic domain is essential for transactivation.
The IE1-VP16AD was found to be a potent activator of
p39CAT-E3, causing an ;8-fold greater activation of
p39CAT-E3 than IE1-OpAD. Slightly higher levels were
observed with IE1-AcAD, which caused 9-fold greater
activation relative to IE1-OpAD. In Sf9 cells, IE1-VP16AD
and IE1-AcAD also show significantly higher levels (4-
fold) of activation of p39CAT-E3 than IE1-OpAD (Fig. 4c).
The pIE1CAT reporter plasmid has been previously
shown to be active in the absence of other viral factors
but could also be transactivated by IE1 (Theilmann and
Stewart, 1992a). Cotransfection of the IE1-AD- with
pIE1CAT in Ld652Y cells (Fig. 4b) resulted in a ;50%
decrease in expression, whereas with IE1-OpAD, ex-
pression of pIE1CAT is approximately doubled. Transac-
tivation by IE1-VP16AD and IE1-AcAD gave ;2- and
4-fold greater expression than IE1-OpAD, respectively. In
Sf9 cells, however, IE1-VP16AD activated to levels only
approximately equivalent to those for IE1-OpAD, but IE1-
AcAD caused a .5-fold increase in IECAT expression.
These results show that the acidic domain of OpMNPV
IE1 can be functionally replaced by the archetype acidic
activation domain from VP16, indicating that IE1 is a
member of the acidic activation domain class of trans-
activators. In addition, both IE1-VP16AD and IE1-AcAD
transactivate p39CAT-E3 to significantly higher levels
than IE1-OpAD. Interestingly, the level of activation for
these chimeric constructs was higher in Ld652Y cells
(9-fold) than in Sf9 cells (3- to 4-fold), suggesting that the
host cell plays a role in determining the relative ability of
these chimeras, and hence the acidic domain, to trans-
activate the reporter genes. These results also show that
for the immediate early ie1 promoter, the IE1 construct
with the AcMNPV acidic domain is a significantly better
activator than either the IE1-OpAD or the VP16 construct.
This contrasts with activation of the delayed-early en-
hancer construct (p39CAT-E3), which was activated
equally well with both IE1-VP16 and IE1-AcAD.
The OpMNPV transcriptional activator IE2 has been
shown to augment IE1 transactivation by transactivating
the ie1 promoter (Theilmann and Stewart, 1992a). In
addition, it has been shown that the ie1 promoter is
autoregulated and transactivated by IE1 and when trans-
activated by both IE1 and IE2 can result in a .4-fold
activation. Similar studies with the p39CAT reporter and
AcMNPV IE1 and IE2 have shown that IE2 will augment
IE1 transactivation ;2.4-fold (Carson et al., 1988). To
determine whether the exchange of the acidic domains
affects the interaction with IE2, the chimeric constructs
were cotransfected with OpMNPV IE2 and IE1CAT or
p39CAT-E3 into Ld652Y and Sf9 cells (Fig. 4).
FIG. 1. Comparison of OpMNPV IE1 acidic domain with three other
baculovirus IE1 proteins. Amino acid alignment of the IE1 acidic do-
mains from four baculovirus species OpMNPV (Theilmann and Stewart,
1991), Choristoneura fumiferana MNPV (CfMNPV) (GenBank accession
no. L04945), Autographa californica MNPV (AcMNPV) (Chis-
holm and Henner, 1988), and Bombyx mori NPV (BmNPV) (Huybrechts
et al., 1992). The IE1 predicted amino acid sequences were aligned
using the UWGCG analysis package. Shown below each row of aligned
sequence is a possible consensus sequence. The numbers above
each row refer to the amino acids. The brackets above and below the
sequence alignment refer to the location of the conserved basic amino
acid clusters.
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In Ld652Y cells (Fig. 4a), cotransfection of p39CAT-E3
with the chimeric IE1 constructs and IE2 resulted in
significant increases in expression. With the wild-type
construct IE1-OpAD, there is a 5.1-fold increase over
expression with IE1 alone; however, the combination of
IE1-VP16AD and IE2 results in an 18-fold increase in
p39CAT-E3 expression. Similar increases were also ob-
served with IE1-AcAD, which also gave an 18-fold in-
crease in p39CAT-E3 expression when cotransfected
with IE2 and compared with IE1-OpAD.
In Sf9 cells, similar to the results observed in Ld652Y
cells, IE1-OpAD and IE2 gave a 5-fold increase over
IE1-OpAD alone (Fig. 4c). The chimeric constructs in Sf9
cells gave significantly larger increases in expression
than IE1-OpAD, but the increases were not as consis-
tently high as in Ld652Y cells. IE1-VP16AD and IE2
caused a 12-fold increase in expression over IE1-OpAD
alone. IE1-AcAD and IE2 gave an 8-fold increase.
Using the pIE1CAT reporter gene in Ld652Y cells,
cotransfection of IE2 with either IE1-AD- or IE1-OpAD
results in a decrease in expression levels with respect to
IE1CAT and IE2 (Fig. 4b). In contrast, cotransfection of
IE2 with IE1-VP16AD and IE1-AcAD results in a 12- and
9-fold increase relative to IE1-OpAD alone, respectively.
In Sf9 cells, in contrast to Ld652Y cells, IE1-AD- causes
an increase in CAT expression when cotransfected with
IE2 even though alone it has no effect on pIE1CAT
expression (Fig. 4d). Interestingly, IE1-AD- has no affect
on p39CAT-E3 when cotransfected with IE2. Similarly,
IE1-OpAD also increases pIE1CAT in Sf9 cells, but again,
the increases observed with IE1-VP16AD and IE1-AcAD
were significantly higher than those with IE1-OpAD.
Overall, these results suggest that the acid transactiva-
tion domain is influenced by both the host cell and the
presence of viral factors.
Previous studies have shown that OpMNPV ie1 is
autoregulatory; therefore, a stronger activation domain
could result in increased levels of IE1, which could result
in increased activation of p39CAT-E3. However, using the
IE1CAT reporter gene (Figs. 4b and 4d), we observed that
VP16 acid domain had only limited affects on autoregu-
lation, whereas the AcMNPV acid domain caused a 4- to
6-fold increase in IE1CAT expression. Therefore, the
greater activity of IE1-VP16AD on the p39CAT-E3 is not
due simply to increased levels of IE1 chimera.
Cotransfection of IE2 with the chimeric IE1 constructs
results in very high overall CAT expression levels, but if
the increases are measured relative to the chimeric IE1
construct in the absence of IE2 (instead of relative to
IE1-OpAD), the increases in expression appear more
modest. In Ld652Y cells, IE2 increases expression over
IE-VP16AD alone an average of 2.2-fold, and for IE1-
AcAD, the increase was an average of 1.9-fold. In Sf9
cells, the average was 3.3-fold for IE1-VP16AD and 2.0-
fold for IE1-AcAD. For the OpIE1 acidic domain, IE2
causes a 5.0-fold increase in both Sf9 and Ld652Y cells.
This suggests that the relative impact of IE2 is greater for
the least potent acidic activation domain.
In both Ld652Y and Sf9 cells cotransfected with
p39CAT-E3 with IE2 in the absence of functional IE1
(p39CAT-E3 and IE1-AD-; Figs. 4a and 4c), it was ob-
served that IE2 caused a small but consistent increase in
expression relative to basal levels. For example, in
Ld652Y cells, transactivation of p39CAT-E3 by IE-2 re-
sulted in a ;6-fold increase in expression, whereas
IE1-OpAD activates p39CAT-E3 expression ;20-fold.
This has not been previously reported and suggests that
IE2 may be weak activator of p39CAT-E3 expression in
FIG. 2. Schematic of wild-type OpMNPV IE1 (IE1-Sal) and the acidic domain chimeric plasmids IE1-AD-, IE1-OpAD, IE1-AcAD, and IE1-VP16AD. (a)
The IE1-AD-construct has the complete acidic domain deleted and a unique ApaI site into which the acidic domains from OpMNPV IE1 (IE1-OpAD),
HSV VP16 (IE1-VP16AD), and AcMNPV IE1 (IE1-AcAD) were inserted. PRM indicates the OpMNPV ie1 promoter; arrow, 59 transcriptional start site;
KR, conserved basic cluster; OpIE1 ORF, OpMNPV ie1 open reading frame; GP, glycine–proline dipeptide insertion at each end of the acidic domain
inserts; M, start methionine; pBS1, pBluscribet. Specific restriction endonuclease sites are indicated. (b) Predicted amino acid sequence of the acidic
domains of the IE1-OpAD, IE1-AcAD, and IE1-VP16AD. Two classes of amino acids are indicated: acidic (2) and basic (1). Previously identified VP16
core activation domains (amino acids 437–447 and 467–479) are underlined (Triezenberg et al., 1988). The lowercase letters at each end of the acidic
domains refer to the glycine–proline dipeptide (indicated as gp) that is encoded by the synthetic linkers used in constructing the plasmids. For the
AcMNPV acidic domain, the lines above the sequence refer to the domains described by Slack and Blissard (1997), and the lines below the sequence
indicate the activation domains mapped by Rodems et al. (1997).
FIG. 3. Western blot analysis of the IE1 chimeric constructs ex-
pressed in Sf9 cells. (a) Sf9 cells were transfected with 1 mg of the
chimera plasmid, IE1-AcAD, IE1-OpAD, or IE1-VP16AD or 1.0 mg of
pBS1 (Mock). Protein from isolated nuclei was electrophoretically sep-
arated by 10% SDS–PAGE. (b) Western blot of total protein isolated from
Sf9 cells transfected with three separate clones of IE1-VP16AD. IE1
chimeras were detected by incubation with IE1-specific rabbit poly-
clonal antisera, and immunocomplexes were detected by incubation
with a peroxidase-conjugated secondary antibody and a chemilumi-
nescent substrate followed by exposure to x-ray film. Filled arrow
indicates the position of the IE1-VP16-specific protein. The positions
and sizes of the molecular weight markers are indicated to the left of
the blots in kilodaltons.
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the absence of IE1 as well as a transactivator of the ie1
promoter.
Cotransfection of chimeric IE1s with IE2 obviously
results in dramatic increase in p39CAT-E3 and pIE1CAT
expression. These results suggest that IE1 and IE2 in-
teract, producing a synergistic increase in the trans-
activation of p39CAT-E3 and that the exchange of the
OpMNPV IE1 acidic activation domain with the VP16 or
AcMNPV IE1 acidic activation domain results in a signif-
icantly more potent transactivation complex. The levels
of transactivation were not consistent between Ld652Y
and Sf9 cells, indicating that there also are cell-specific
factors affecting IE1-IE2 transactivation. This could be
due to factors that affect the level of expression or
interact directly with IE1 or IE2.
Deletion analysis of the IE1 acidic domain
The chimeric OpMNPV proteins confirmed that the
N-terminal acidic domain of OpMNPV IE1 functioned as
an acidic activation domain. To further these studies,
deletion analyses were performed to identify functional
core domains or essential amino acids within the OpM-
NPV acidic activation domain. Thirty-two N- and C-termi-
nal deletions were generated from both ends of the
OpMNPV IE1 acidic domain as shown in Fig. 5. The
N-terminal deletions span the acidic domain of OpMNPV
IE1 from amino acid 14 to 143 and the C-terminal dele-
tions span from amino acid 126 to 3. With the large
number of deletions, we expected to be able to identify
smaller functional subdomains similar to the core acti-
FIG. 4. IE1 chimeras transactivation analysis of p39CAT-E3 (a and c) or pIE1CAT (b and d) reporter plasmids in Ld652Y (a and b) and Sf9 cells
(c and d). The pIE1CAT (1 mg) or p39CAT-E3 (1 mg) reporter plasmid was cotransfected with 1 mg of the indicated transactivator plasmid
(IE1-AD-, IE1-OpAD, IE1-VP16AD, IE1-AcAD) with 0.5 mg IE2 (hatched columns) or without IE2 (filled columns). All CAT activities obtained are
reported relative to the reporter plasmid cotransfected with IE1-OpAD, which was given an arbitrary value of 100. The error bars represent the
standard deviation.
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vation domains found in the mammalian transactivator
VP16 and the yeast factor Gal4.
Deletion of specific amino acid sequences of a protein
can result in it being unstable and rapidly degraded. To
confirm that we were able to express the IE1 deletion
mutants, each construct was transfected and analyzed
by Western blotting (Figs. 6a and 6b). Using polyclonal
antisera, we were able to detect all of the N- and C-
terminal deletions, including the IE1-AD- construct,
which lacks the entire acidic domain. The Western blot
analysis confirms that all of the IE1 N- and C-terminal
deletion mutants were expressed and that all were trans-
located to the nucleus. Lack of transactivation by these
mutants therefore is not due either to the absence of
expressed protein or nuclear localization. The two bands
observed for D14–106 and D14–107 in Fig. 6a could be a
result of variable phosphorylation, which has been
shown to result in multiple species of IE1 to be observed
on SDS gels (Choi and Guarino, 1995; Theilmann and
Stewart, 1993a).
To assay the activity of each construct, the deletion
plasmids were cotransfected with either the p39CAT-E3
reporter gene or the pIE1CAT reporter construct into
Ld652Y and Sf9 cells. In Ld652Y cells, deletions of amino
acids 14–27 did not adversely affect p39CAT-E3 expres-
sion levels relative to wild-type levels (Fig. 7a). However,
deletion mutant D14–27 had expression levels that were
significantly higher (226%) than those of wild type. Dele-
tion of an additional 16 amino acids (D14–43) resulted in
a 94% decrease in p39CAT-E3 expression, indicating that
this region is essential for the function of the acidic
activation domain. Deletion mutants D14–43 through
D14–80 had drastically reduced activity that was very low
but consistently above background except for deletion
D13–62, which had no detectable activity. The activity of
these mutants ranged from 4% to 13% relative to wild
type. The most active mutants of this group were mutants
D14–52 and D14–76 with expression levels of 13% rela-
tive to wild type. For deletions beyond amino acid 80, the
CAT expression levels were equivalent to reporter gene
background levels. This suggests that a residual or
weakly active activation domain is located between
amino acids 80–127.
In Sf9 cells, similar results were obtained (Fig. 7c); for
the deletion mutants D14–25 and D14–27, the p39CAT-E3
expression levels were 107% and 335% of wild-type,
respectively. Further deletion of amino acids 28–43 (D14–
43) results in complete loss of transactivation, confirming
that amino acids 28–43 are essential for transactivation.
Unlike Ld652Y cells, in which residual activity was re-
tained up to amino acid 80, only deletion D14–76 had
expression levels significantly above background. This
suggests that the residual activation domain between
amino acids 80–127 is not sufficiently potent to be de-
tectable in Sf9 cells. However, the mutant D14–76, which
gave detectable activity, also was the most active mutant
beyond amino acid 27 in Ld652Y cells, which suggests
that this specific mutant enables the residual activation
domain to be in a more active conformation and there-
fore detectable using an enhancer-dependent reporter
gene in both cell types.
To analyze enhancer-independent transactivation, the
FIG. 5. The amino acid sequence of the OpMNPV IE1 acidic domain N-terminal (a) or C-terminal (b) deletion constructs. The predicted amino acid
sequence of the wild-type IE1 acidic domain is situated on the first line, followed by the deletion mutants listed in descending order by predicted size.
Each deletion mutant has been designated according to the amino acids that have been deleted, as indicated in parentheses. The symbols at the
top refer to the charge distribution along the length of the IE1 acidic domain: acidic amino acids (2) and basic amino acids (1). The lowercase g
in the C-terminal deletions refers to the glycine that is encoded by the synthetic linkers used to construct IE1-AD-.
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N-terminal deletions were cotransfected with pIE1CAT
into Ld652Y and Sf9 cells (Figs. 7b and 7d). In Ld652Y
cells, wild-type IE1 produces a 2.6-fold increase in
pIE1CAT expression. As in the enhancer-dependent
studies, mutant D14–25 gave wild-type levels of expres-
sion; however, mutant D14–27, which gave two to three
times the expression levels of wild type using p39CAT-
E3,had only wild-type levels of expression. For deletions
beyond amino acid 27, only one mutant, D14–76, pro-
duced activated expression levels equal to 68% of wild-
type IE1. This result suggests that the region from amino
acids 76–127 is sufficient for pIE1CAT enhancer-inde-
pendent activation.
In Sf9 cells (Fig. 7d), results of pIE1CAT transactiva-
tion were very similar. The expression levels of mu-
tants D14–25 and D14–27 were not significantly different
from wild type. In addition, mutant D14–76 was the only
mutant beyond amino acid 27 that had detectable activ-
ity. The major cell-specific difference observed with the
pIE1CAT reporter gene was that in Sf9 cells, wild-type
IE1 causes a 7-fold increase in expression in contrast
to an increase of 2.6-fold in Ld652Y cells. When compar-
ing the enhancer-dependent and -independent results,
clear differences are apparent with the deletion mutant
D14–27. For the mutant D14–27, the CAT expression lev-
els were a very large (335% of wild type) with the en-
hancer-containing reporter but only equivalent to wild
type with the enhancerless reporter construct. These
data suggest that the OpMNPV enhancer may permit
transcription complex interactions that are enhanced by
deletion of amino acids 14–25 but do not occur on the ie1
promoter. The N-terminal deletion analysis has shown
FIG. 6. Western blot analysis of IE1 acidic domain N-terminal (a) and C-terminal (b) deletion constructs expression and nuclear localization in Sf9
cells. Cells were transfected with either 5 mg of IE1-Sal (WT), 5 mg of an IE1 deletion plasmid, or 0.5 mg IE2. Total cell protein from 1.0 3 105 cells
was electrophoretically separated by 10% SDS–PAGE. Proteins were transferred to membranes and probed with IE1-specific antisera. Immunocom-
plexes were detected as indicated in Fig. 3. Dots indicate IE1-specific bands. N indicates nuclear fraction. C indicates cytoplasmic fraction molecular
weight standards indicated to the left of each blot in kilodaltons.
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that there appears to be specific subdomains of the IE1
acidic domain that are required for transactivation of
early promoters. Amino acids 28–43 are essential for
wild type or greater transactivation of the p39CAT-E3 and
pIE1CAT reporter genes. For low-level transactivation of
p39CAT-E3, amino acids 80–127 are required.
The N-terminal deletions identified two possible borders
of subdomains within the acidic activation domain of OpM-
NPV IE1. To identify the C-terminal borders of these regions,
the series of C-terminal deletions were used (Fig. 5b). Nine
C-terminal deletion mutants were constructed spanning the
OpMNPV IE1 acidic domain from Ser-16 to Asp-124. The
null mutant, IE1-AD-, lacks the entire acidic domain from
Lys-3 to Ser-126. The IE1 C-terminal deletion mutants were
cotransfected with p39CAT-E3 and pIE1CAT into Ld652Y
and Sf9 cells (Fig. 8).
Transactivation of p39CAT-E3 in Ld652Y cells (Fig. 8a)
by D113–124 caused an 80% drop in CAT expression,
D91–124 resulted in a further 10% drop, and C-terminal
deletions beyond amino acid 78 had no detectable ac-
tivity. In Sf9 cells (Fig. 8c), the smallest deletion, D113–
124, a deletion of 12 amino acids, produced a ;80%
FIG. 7. IE1 acidic domain N-terminal deletion constructs transactivation analysis of p39CAT-E3 (a and c) or pIE1CAT (b and d) reporter plasmids
in Ld652Y (a and b) and Sf9 (c and d) cells. The pIE1CAT (1 mg) or p39CAT-E3 (1 mg) reporter plasmid was transfected with 1 mg of the indicated
plasmid (Fig. 5a). Mock indicates cells transfected with 2 mg of pBS1. The CAT activity obtained from the reporter plasmid cotransfected with the
wild-type WT IE1 construct (IE1-Sal) was given an arbitrary value of 100%. The error bars represent the standard deviation.
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decrease in CAT expression levels relative to the wild-
type IE1 construct. On deletion of an additional 22 amino
acids, D91–124, expression levels decreased to ;10% of
wild type. Levels decreased to ,10% of wild type with
D78–124, D73–124, and D66–124. Deletion of an addi-
tional 26 amino acids (D45–124) or more resulted in
expression levels below background. These results sug-
gest that amino acids 1–65 represent the minimum se-
quence that permitted low-level transactivation of
p39CAT-E3 and that amino acids 1–124 are required for
full activity. The null mutant IE1-AD- produced activity
levels equivalent to reporter background.
Enhancer-independent transactivation by the C-ter-
minal deletion mutants was assayed using the
pIE1CAT reporter construct in both Ld652Y and Sf9
cells (Figs. 8b and 8d). In contrast to p39CAT-E3, none
of the deletion mutants in either cell type were capable
of transactivating pIE1CAT above reporter construct
alone in either Ld652Y cells or Sf9 cells (Figs. 8b and
8d). Therefore, amino acids 91–124 must be retained
FIG. 8. IE1 acidic domain C-terminal deletion constructs transactivation analysis of p39CAT-E3 (a and c) or pIE1CAT (b and d) reporter plasmids
in Ld652Y (a and b) and Sf9 (c and d) cells. Then, 1 mg of pIE1CAT or p39CAT-E3 reporter plasmid was transfected with 1 mg of the indicated plasmid
(Fig. 5b). Mock indicates cells transfected with 2 mg of pBS1. The CAT activity obtained from the reporter plasmid cotransfected with WT4 (see Fig.
3), the full-length OpMNPV IE1 construct, was given an arbitrary value of 100%. The error bars represent the standard deviation.
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for any transactivation activity on the enhancer-less
ie1 promoter.
DISCUSSION
Regulation of baculovirus gene expression involves a
cascade of regulatory events and depends on complex
interactions between viral and cellular transcriptional
regulatory proteins and cis-acting DNA elements. The
baculovirus transcription factor IE1 has been shown by
numerous studies to be central to baculovirus gene ex-
pression and DNA replication. Typically, transcriptional
regulatory proteins are made up of a DNA–protein bind-
ing domain and a regulatory domain. Regulatory do-
mains can be multifunctional, in some cases activating
expression of specific genes while repressing expres-
sion of others. The objectives of this study were to
determine whether the acidic N-terminal end of OpMNPV
IE1 functioned as an acidic activation domain and
whether changes in that domain could affect transacti-
vation potential. The second objective was to map by
deletion analysis regions of the acidic N-terminus to
determine the amino acids essential for activation.
To determine whether the OpMNPV IE1 acidic domain
was an acidic activation domain, the OpMNPV acidic
domain was deleted and replaced with the acidic do-
main from the archetype acidic activation domain of the
HSV transactivator VP16 (Cousens et al., 1989; Sadowski
et al., 1988; Triezenberg et al., 1988) and the IE1 acidic
domain from the archetype baculovirus AcMNPV, which
has a greater host range than OpMNPV. The IE1 chimeric
constructs therefore contained variable acidic domains
and the OpMNPV IE1-DNA binding domain. When the
acidic domain of OpMNPV IE1 was deleted, transactiva-
tion activity was eliminated (Figs. 4a and 4b), demon-
strating that the OpMNPV IE1 acidic domain is required
for transactivation, similar to what has been shown for
AcMNPV IE1 (Kovacs et al., 1992; Rodems et al., 1997;
Slack and Blissard, 1997). Replacement of the OpMNPV
acidic domain with the archetype HSV VP16 acidic acti-
vation domain resulted in a chimeric IE1 (IE1-VP16AD)
that was significantly more potent than the native OpM-
NPV construct (IE1-OpAD) (Figs. 4a and 4c). Interestingly,
the AcMNPV acidic domain can also replace the OpM-
NPV acidic domain, again resulting in a much more
potent transcriptional transactivator of p39CAT-E3 than
IE1-OpAD.
These results indicate that the activation domain of
OpMNPV is a member of the acidic class of transcrip-
tional transactivators because it can be functionally re-
placed by the archetype VP16 acidic activation domain.
The VP16 activation domain has been shown to be one of
the most potent transcriptional activators known (Sa-
dowski et al., 1988). Of all the classes of transcriptional
activators, the acidic class is unique in its ability to
function in a wide range of eukaryotes from yeast to
humans (Hahn, 1993). This study demonstrates that the
VP16 activation domain will also function in lepidopteran
insect cells.
Previous studies have shown that IE2 augments the
transactivation of early promoters by IE1, ostensibly by
activation of the ie1 promoter (Carson et al., 1988; Theil-
mann and Stewart, 1992a). When IE2 was cotransfected
with the IE1 chimeras into Ld652Y and Sf9 cells, syner-
gistic increases in CAT expression levels were observed.
Interestingly, it was observed that IE2 consistently trans-
activated p39CAT-E3 (Figs. 5a and 5c), which has not
been previously reported. Therefore, the synergism ob-
served between IE1 and IE2 may not be due simply to
interactions on the ie1 promoter but also to interactions
on the enhancer or promoter regions of p39CAT-E3.
Our results showed that the chimeric constructs were
more potent activators. This suggests that the AcMNPV
IE1 and VP16 acidic activation domains are more effi-
cient at interacting with the transcriptional machinery
than the OpMNPV IE1 acidic activation domain. AcMNPV
is more virulent and has a broader host range than
OpMNPV, and it is possible that IE1 could play a role in
these differences.
Deletion analysis of the OpMNPV IE1 acid domain
A deletion analysis of the OpMNPV acidic domain was
carried out to map the minimal sequence requirements
for transactivation. In addition, we were interested in
determining whether there were any cell-specific differ-
ences in domain requirements and whether the require-
ments differed for enhancer-dependent and-independent
transactivation.
Deletion analysis of the amino-terminal acidic region
of OpMNPV IE1 revealed two core regions that are crit-
ical for activation by the OpMNPV acidic activation do-
main: an N-terminal subdomain (amino acids 28–43) and
a C-terminal subdomain (amino acids 113–124) (Fig. 9).
For the N-terminal deletions, the region from amino acid
28–126 was required for wild type or greater activation
levels, whereas amino acids 77–126 are required for very
low-level activation. This very weak activation may be
due to the presence of the intact C-terminal core region
(amino acids 113–124). The C-terminal deletions demon-
strated that the region from residues 1–126 was required
for wild-type level activation, whereas amino acids 1–65
were required for low-level activation. This low-level ac-
tivation may be due to the presence of an intact N-
terminal subdomain (amino acids 28–43). The majority of
the deletion mutants contain an intact activation domain
at the end opposite the site of deletion; however, the loss
of activation function occurs well before either of the
activation domains are deleted. Thus neither of the crit-
ical subdomains are sufficient for activation by them-
selves.
For the C-terminal deletions of the OpMNPV IE1 acidic
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activation domain, the results obtained using the en-
hancer-dependent reporter gene p39CAT-E3 were very
different from those obtained with the enhancer-indepen-
dent reporter gene pIE1CAT. For the p39CAT-E3 studies,
a gradual decline in activity was observed as the size of
the deletion increased. However, for the enhancer-inde-
pendent studies, no activity was observed for any of the
deletion mutants. Studies on AcMNPV IE1 showed that
when IE1 is present in limiting quantities, the p39CAT
reporter gene requires an enhancer element for detect-
able expression levels (Choi and Guarino, 1995). We may
be observing a similar situation with the C-terminal de-
letion mutants. Their activity may be so low that it is
undetectable using the enhancer-independent reporter
gene. Because the deletion mutants are transcribed from
the IE1 promoter that is autoregulatory, mutants that
have very weak activity may not produce sufficient IE1 to
transactivate the enhancer-independent pIE1CAT re-
porter gene. For the enhancer-dependent studies, the
p39CAT-E3 reporter gene may require much smaller
quantities of IE1 protein for activation. Choi and Guarino
(1995) observed that activation of an enhancer-contain-
ing reporter gene was maximal at a concentration of
AcMNPV IE1 that was 50-fold less than that required for
activation in the absence of enhancer.
The two OpMNPV acidic activation subdomains
shown to be critical for high levels of transactivation are
reminiscent of the two VP16 acidic activation subdo-
mains: the proximal N-terminal subdomain (amino acids
413–456) and the distal C-terminal subdomain (amino
acids 453–490) (Cress and Triezenberg, 1991; Goodrich
et al., 1993; Regier et al., 1993; Walker et al., 1993) (Fig.
9b). Mutational analysis identified a critical phenylala-
nine residue within each subdomain: Phe-442 and Phe-
473, respectively. Both phenylalanine residues are sur-
rounded by a similar pattern of amino acids: alternating
hydrophobic and acidic amino acids. When we com-
pared the two subdomains of the OpMNPV acidic acti-
vation domain with two core activation domains from
VP16 and one from GAL4, we observed a similar pattern
of a central phenylalanine flanked by alternating acidic
and hydrophobic amino acids for the IE1 N-terminal
FIG. 9. Summary of the OpMNPV IE1 acidic domain deletion analyses. (a) The amino acid sequences identified by deletion analysis as essential
for transactivation function are indicated by double underlining. The N-terminal deletion and C-terminal deletion labels refer to the particular deletion
set that was used to identify the minimal sequences required for transactivation. The thick lines indicate sequences required for high-level
transactivation, and the thin lines refer to sequences required for detectable low-level transactivation. Three classes of amino acid are indicated:
acidic (red), basic (blue), and hydrophobic (green). The distribution of charges along the length of the acidic domains is also shown above each
sequence: acidic amino acids (2) and basic amino acids (1). (b) Comparison of the OpMNPV IE1 core activation domains with the core domains of
VP16 and Gal4. The predicted amino acid sequence of the OpMNPV IE1 core activation domains (amino acids 28–43 and 113–124) compared with
the core domains of the mammalian transactivator VP16 (Triezenberg et al., 1988) and the yeast factor Gal4 (Ma and Ptashne, 1987). The different
classes of amino acid are color coded: acidic amino acids (red) and hydrophobic amino acids (green). The N-terminal and C-terminal deletion labels
refer to the particular deletion set that was used to identify the OpMNPV IE1 core activation domains.
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subdomain (amino acids 28–43) (Fig. 9b). Although the
IE1 C-terminal subdomain (amino acids 113–124) lacks a
central phenylalanine, an almost central bulky hydropho-
bic valine residue is flanked by alternating acidic resi-
dues.
In recent studies, Slack and Blissard (1997) and Ro-
dems et al. (1997) performed analyses on the acidic
domain, DNA binding, and oligomerization domain of
AcMNPV IE1. Using a heterologous system, Slack and
Blissard (1997) separated the N-terminal half of AcMNPV
into six regions (1A, 2A, B, C, D, and E) based on charge
distribution (Fig. 2) (the chimera IE1-AcAD used in this
study contained regions 1A, 2A, B, and half of C). This
study found that regions 1,2A, and B, but not C, could
weakly act as activation domains when linked to the
Escherichia coli Lac repressor protein DNA binding do-
main. Combined, 1,2A, B, and C were much stronger than
the individual domains, but removal of region C resulted
in another 2-fold increase in expression. This suggests
that the conserved basic domain (region C) (Figs. 1 and
2) may act as an inhibitory domain. However, Rodems et
al. (1997) suggests that the basic domain may also be
involved in DNA binding. Rodems et al. (1997) also ana-
lyzed the N-terminal domain of AcMNPV IE1 using a
heterologous system (Gal4 DNA binding domain) and
found that amino acids 8–51 (Fig. 2) functioned as a weak
activation domain but amino acids 8–118 activated 5-fold
greater. The findings of these AcMNPV IE1 studies are
similar to the results presented in this study in that they
also suggest that the OpMNPV acidic domain is com-
posed of subdomains that have maximal activity when
combined.
Slack and Blissard (1997) found that amino acids 168–
222 of AcMNPV IE1 also functioned as an activation
domain in the heterologous system. This region, unlike
the N-terminal region acidic domain, has 39% sequence
identity compared with OpMNPV IE1. This region is main-
tained in our IE1-AD- construct (Fig. 2), but this construct
was not found to have any activation function when
cotransfected with pIE1CAT or p39CAT-E3. However,
when cotransfected with IE2, it was observed that it
caused an increase in pIE1CAT expression compared
with IE2 alone in Sf9 cells but not in Ld652Y cells (Fig.
4d). This suggests that under specific conditions, the
IE1-AD- construct contains an additional activation do-
main, possibly the region homologous to AcMNPV IE1
amino acids 168–222.
These studies have shown that the acidic domain of
OpMNPV IE1 functions as an acidic activation domain.
IE1 chimeric proteins containing the VP16 acidic acti-
vation domain and the AcMNPV IE1 acidic domain
clearly outperform the wild-type OpMNPV IE1 protein
in transient transactivation analyses. The difference in
activity levels becomes even more pronounced in the
presence of IE2 because dramatic synergistic in-
creases in CAT expression levels are observed when
the IE1 chimeras are used. Finally, deletion analysis of
the OpMNPV IE1 acidic domain revealed two subdo-
mains that are required for high-level transactivation.
Future mutational and structural studies will increase
our knowledge of this insect transactivator and enable
us to better understand mechanisms of baculovirus
gene regulation.
MATERIALS AND METHODS
Cell culture
Sf9 cells were propagated in TC-100 media as previ-
ously described (Summers and Smith, 1987). Ld652Y
cells were maintained in TC-100 media supplemented
with 0.5% bovine serum albumin (Fraction V, Sigma).
Plasmid constructs
Reporter, IE1, and IE2 constructs.The p39CAT-E3
and pIE1CAT reporter constructs have been described
previously (Theilmann and Stewart, 1991, 1992b) The
OpMNPV IE1 clone that was used in the transient
assays has been previously described as Op47Sal-
IE-1 (Theilmann and Stewart, 1993b) and was desig-
nated IE1-Sal in this study. The OpMNPV IE2 plasmid
(IE2-E2.3) used in cotransfections to enhance IE1
transactivation activity has been described elsewhere
(Theilmann and Stewart, 1992a).
Acidic domainless construct.The OpMNPV IE1 acidic
domainless plasmid (IE1-AD-) was constructed by delet-
ing the DNA that encodes the OpMNPV IE1 acidic do-
main from IE1-Sal (Fig. 2). The acidic domain was de-
leted by PCR mutagenesis as previously described (Nel-
son and Long, 1989), and a unique ApaI site, indicated
below as the underlined sequence of primer A, was
inserted in place of the deleted acidic domain directly
downstream of the first ATG of the OpMNPV IE1 ORF.
Briefly, this mutagenesis protocol includes three steps:
(1) a 30-cycle amplification using primers A and B (as
shown below), (2) a one-cycle elongation step using the
denatured step 1 PCR product as primer, and (3) a
30-cycle PCR using primers C and D. PCR was per-
formed using Taq DNA polymerase according to the
manufacturer’s specifications (Life Technologies) in 1.5
mM MgCl2, 1 ng of template DNA, and 1 mM concentra-
tion each of the 59 and 39 primers, except in step 2,
where 6 nM of denatured step 1 PCR product served as
the 59 primer. One denaturation cycle of 95°C for 2 min
was followed by 30 cycles of 1 min at 95°C, 2 min at the
optimal annealing temperature for each primer pair
(54°C for steps 1 and 3 and 66°C for step 2), 1 min 30 s
at 72°C, and a final extension cycle of 10 min at 72°C.
The DNA template for all steps was IE1-Sal, and the four
oligonucleotide primers, designated A–D as in the above
report, were primer A, 59-gcgcgcagcacctttgcgatggggc-
ccaagggcaaaaagct ggtcaacaag-39; primer B, 59-ctgct-
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cagtcagtcctagatacttcatgatttgcgccacg-39; primer C, 59-
aaacgataacgccgttg-39; and primer D, 59-ctgctcagtcagtc-
ctagat-39.
The resulting amplification products were excised
from a 2% TAE agarose gel and extracted using the
Geneclean method (Bio 101). To obtain the final IE1-AD-
construct, the purified amplification product was di-
gested with BstXI and EcoNI (New England Biolabs), gel
purified from TAE agarose as described above, and li-
gated to a BstXI–EcoNI cut IE1-Sal vector (Op47Sal-IE-1
(Theilmann and Stewart, 1993b)). Final constructs were
confirmed by nucleic acid sequencing.
Acidic domain chimeric constructs.PCR was used to
synthesize the acidic domain replacement inserts as
described above in 1.5 mM MgCl2 except where noted.
PCR amplifications were carried out using 100 ng of
template DNA and 0.5 mM concentration each of the 59
and 39 primers. The DNA templates consisted of IE1-Sal
for the wild-type OpMNPV IE1 acidic domain (OpAD),
pAcIE1 (Theilmann and Stewart, 1991) for the AcMNPV
IE1 acidic domain (AcAD), and pSGVPD 490 for the VP16
acidic domain (VP16AD) (kindly provided by Ivan Sadow-
ski, Department of Biochemistry and Molecular Biology,
University of British Columbia). One denaturation cycle of
94°C for 2 min was followed by 30 cycles of 45 s at 94°C,
30 s at the optimal annealing temperature for each
primer pair (OpAD, 63°C in 1.3 mM MgCl2; AcAD 58°;
VP16AD, 64°C), 1 min 30 s at 72°C, and a final extension
cycle of 10 min at 72°C. The resulting amplification
products were excised from a 2% TAE agarose gel and
purified using the Geneclean method (Bio 101). To am-
plify the acidic domain inserts, the following primer pairs
were used: OpAD, 59-TTTgggcccCCCAAGAATATGGAAA-
CTCTACAGCGTTCG-39 and 59-tttgggcccTGAAGAGTCGT-
CGCTGTCCGAGTCGCTGTC-39; AcAD, 59-GTGgggcccACG-
CAAATTAATTTTAACGCGTCGTACACC-39 and 59-tttgggc-
ccGTTAAACTGGCCCACCACACCTTGTG-39; and VP16AD,
59-CTGgggcccGCCCCCCCGACCGATGTCAGCC-39 and
59-cgcgggcccCCCACCGTACTCGTCAATTCCAAGGGCATC-39.
The ApaI sites that were used for ligating the inserts
to ApaI-linearized IE1-AD- vector are underlined. To
obtain the full-length OpAD insert, an ApaI partial
digest was required because this fragment contains
an internal ApaI site. All constructs were confirmed by
sequencing.
N-terminal deletion constructs.To make the OpMNPV
IE1 acidic domain N-terminal) deletion plasmids, IE1-Sal
was linearized with ApaI and treated with Bal-31 nucle-
ase for 11–20 min. Aliquots were removed at 1- to 2-min
intervals, and digestion was stopped by adjusting the
mixture to a final concentration of 100 mM EGTA (pH 8.0).
The ends were made blunt with T4 DNA polymerase (Life
Technologies). Because Bal-31 nuclease digests DNA
bidirectionally, the deletions also extended 59 from the
ApaI site into the promoter region of OpMNPV IE1; there-
fore, this promoter region had to be restored. To do so,
the promoter region was completely removed by diges-
tion with ScaI, which cuts upstream of the OpMNPV IE1
59 sequence (Fig. 2a). To obtain the OpMNPV IE1 pro-
moter fragment, IE1-Sal was digested with ApaI, blunt-
ended with T4 DNA polymerase, and digested with ScaI,
and the ScaI–ApaI fragment was gel purified. This pro-
moter-containing fragment was ligated to the Bal-31 de-
leted vector fragments to obtain plasmids that pos-
sessed intact OpMNPV IE1 promoters. DNA sequence
analysis (Sanger et al., 1977) was used to screen for
deletion mutants that were in the correct reading frame.
Predicted sizes of the IE1 N-C deletion constructs (in Da)
are as follows: D14–25, 62982; D14–27, 62810; D14–43,
60958; D14–44, 60901; D14–52, 60036; D14–56, 59590;
D13–62, 58718; D14–66, 58393; D14–68, 58219; D14–74,
57591; D14–76, 57363; D14–80, 56975; D14–84, 56513;
D14–85, 56442; D14–95, 55454; D14–96, 55340; D14–104,
54624; D14–105, 54553; D14–106, 54482; D14–107, 54425;
D14–121, 52963; D14–127, 52344; D14–143, 50379; and
D2–126 (AD-), 51235.
C-terminal deletion constructs.The OpMNPV IE1
acidic domain C-terminal deletions were constructed by
ligating PCR-amplified inserts of the OpMNPV IE1 acidic
domain that were blunt-ended with HincII (Life Technol-
ogies) into an ApaI-cut, T4 DNA polymerase blunt-ended
IE1-AD-vector. The oligonucleotides that were used as
primers were a common 59 primer (59-TGGTCGACCCAA-
GAATATGGAAAC-39) and the following deletion-specific
39 primers: D113–124, 59-ccgtcgaCGACTTGCGTTTGG-
AGC-39; D91–124, 59-ccgtcgaCGAGTCGGCGCTAAACC-39;
D78–124, 59-acgtcgaCGACTCGCGCGCCAGTTC-39; D73–
124, 59-ccgtcgaCGAGTCCACGGCGCACGCCA-39; D66–124,
59-cggtcgaCGACTTTTTGCTGCGGTC-39; D45–124, 59-tggtc-
gaCGAGCCGTCGTAGGGGAC-39; D36–124, 59-ccgtcgaC-
GAAAAGTTTAGGTCGTCC-39; D27–124, 59-gcgtcgaCGA-
GGCATTGTTGAACAAAT-39; and D16–124, 59-ttgtcgaCG-
ACGGGCCCATATACG-39.
The deletions are designated according to the
amino acids deleted, and the HincII recognition se-
quence is underlined. PCR was carried out as de-
scribed above using Taq DNA polymerase (Life Tech-
nologies) or Pfu DNA polymerase (Stratagene) in 1.5
mM MgCl2 except as indicated, 100 ng of IE1-Sal
as template, and primers at 0.4 mM concentration
each. Amplification conditions were one denaturation
cycle of 2 min at 95°C, followed by 30 cycles of 45 s
at 95°C, 30 s at the optimal annealing temperature
(50°C for wild type, D113–124, and D91–124; 53°C
in 1.3 mM MgCl2 for D16–124; 52°C for all others), and
1 min at 72°C. A single cycle was performed with a
final elongation of 10 min at 72°C. All constructions
were verified by nucleic acid sequencing. Predicted
sizes of the IE1 C-N deletion constructs (in Da) are as
follows: D113–124, 63109; D91–124, 61013; D78–124,
59744; D73–124, 59044; D66–124, 58472; D45–124,
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56077; D36–124, 55111; D27–124, 54067; and D16–124,
52857.
Transient assays
Cells were transfected with plasmid constructs us-
ing the CellFECTIN Reagent (Life Technologies) ac-
cording to the manufacturer’s protocol or using lipo-
somes prepared as previously described (Campbell,
1995). Briefly, 1 3 106 cells were seeded onto 6-well
(35-mm) cell culture dishes in TC-100 media and al-
lowed to adhere for 1 h. The media was removed, and
the cells were washed with 13 Grace’s media and
then incubated with a DNA–liposome mixture in
Grace’s media at 27°C for 6 hr. The DNA–liposome
mixture was removed, and the cells were washed with
13 Grace’s media and then overlaid with TC-100 me-
dia containing 50 mg/ml of the antibiotic gentamicin
sulfate (Life Technologies) and incubated at 27°C for
48 hr. Cells were harvested with a rubber policeman,
gently pelleted, washed, and resuspended in PBS (10.1
mM Na2HPO4, 1.8 mM KH2PO4, 2.7 mM KCl, 136 mM
NaCl, pH 7.2). Transfections were done in duplicate
and included 1 mg of transactivator plasmid and 1 mg
of reporter plasmid per 1 3 106 cells. For Western blot
analysis of the N- and C-terminal deletions in Sf9 cells,
5 mg of IE1 plasmid and 0.5 mg of IE2 plasmid were
used per transfection.
For the CAT aliquot, cells were pelleted, resuspended
in 100 ml of 250 mM Tris–HCl (pH 7.4), lysed by three
freeze (285°C)/thaw (37°C) cycles, and heated to 65°C.
Cell debris was pelleted, and the supernatants contain-
ing the cell extracts were used for the CAT assays as
previously described (Leahy et al., 1995; Neuman et al.,
1987). These assays were performed in 125 ml of reaction
mixture containing the cell extract sample, 5 mM chlor-
amphenicol (Sigma), 200 mM Tris–HCl (pH 7.4), and 3H-
acetyl-CoA (NEN-290L, New England Nuclear). All CAT
assay activity values were obtained under conditions
where the rate of activity falls within a linear range. For
all CAT assays, a minimum of four separate transfections
were performed.
Western blots
Nuclear and cytoplasmic fractions for analysis by
Western blots were isolated by the following method.
Cells were harvested, pelleted at 3000 rpm for 5 min,
washed with chilled PBS, and repelleted. Cells were
resuspended in Nonidet P-40 lysis buffer [10 mM Tris,
pH 7.9, 10 mM NaCl, 5 mM MgCl2, 1 mM DTT, 0.5%
Nonidet P-40 (v/v)] at a concentration of 2 3 107
cells/ml. Cells were gently mixed and kept on ice for 5
min. Nuclei were pelleted by centrifugation at 1000 g
for 3 min. The supernatant (cytoplasmic fraction) was
removed and mixed with an equal volume of 23 pro-
tein sample buffer (PSB) (250 mM Tris–HCl, pH 6.8, 4%
SDS, 20% glycerol, 10% 2-mercaptoethanol, 0.002%
bromphenol blue). The nuclei were resuspended in the
original volume of lysis buffer and mixed with an equal
volume of 23 PSB to form the nuclear fraction. DNA in
the nuclear fraction was sheared with a 25-gauge
syringe (Jarvis et al., 1992; Nevins, 1987). SDS–PAGE
and Western blot analysis were performed using stan-
dard techniques (Laemmli, 1970; Sambrook et al.,
1989). Proteins were transferred onto Immobilon-P
(Millipore) polyvinylidene fluoride (PVDF) membrane
or Hybond-C (Amersham Life Science) nitrocellulose
membrane. Western blots were incubated in the pres-
ence polyclonal antisera for 1 h. The anti-IE1 poly-
clonal antisera was raised in rabbits by injecting them
with a primary antigen composed of pGEX-IE1 fusion
proteins containing amino acids 15–560 and 387–560
purified from bacterial lysates. Rabbits were boosted
with pGEX-IE1 fusion proteins containing only amino
acids 387–560 purified from bacterial lysates (Harlow
and Lane, 1988). Immunoreactive complexes were de-
tected using anti-mouse or anti-rabbit peroxidase- or
alkaline phosphatase-linked secondary antibodies
(Jackson Laboratories) followed by development with
5-bromo-4-chloro-3-indolyl phosphate and nitro blue
tetrazolium (Life Technologies), a chemiluminescent
substrate (ECL; Amersham Life Science), or a chemi-
fluorescent substrate (Attophos; Molecular Dynamics
and Amersham Life Sciences) using the manufactur-
ers specifications. The PVDF membranes were
stripped and reprobed as previously described (Suck
and Krupinska, 1996), and the Hybond-C (Amersham
Life Sciences) nitrocellulose membranes were
stripped and reprobed as specified by the manufac-
turer.
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